Insmed Inc (INSM)
24.79
-1.39
(-5.31%)
USD |
NASDAQ |
Apr 18, 16:00
24.79
0.00 (0.00%)
After-Hours: 20:00
Insmed Revenue (TTM): 305.21M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 305.21M |
September 30, 2023 | 280.82M |
June 30, 2023 | 269.47M |
March 31, 2023 | 257.46M |
December 31, 2022 | 245.36M |
September 30, 2022 | 242.18M |
June 30, 2022 | 221.21M |
March 31, 2022 | 201.35M |
December 31, 2021 | 188.46M |
September 30, 2021 | 173.75M |
June 30, 2021 | 170.64M |
March 31, 2021 | 167.77M |
December 31, 2020 | 164.41M |
September 30, 2020 | 168.71M |
June 30, 2020 | 163.95M |
March 31, 2020 | 151.42M |
December 31, 2019 | 136.47M |
September 30, 2019 | 100.59M |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | 4.417M |
September 30, 2011 | 4.335M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
100.59M
Minimum
Sep 2019
305.21M
Maximum
Dec 2023
200.51M
Average
181.11M
Median
Revenue (TTM) Benchmarks
NeuroMetrix Inc | 5.901M |
Intra-Cellular Therapies Inc | 462.18M |
Rhythm Pharmaceuticals Inc | 77.43M |
Amylyx Pharmaceuticals Inc | 380.79M |
AN2 Therapeutics Inc | -- |